Merck said the deal will enable it to expand its portfolio with CD388, a long-acting antiviral aimed at preventing flu in people at high risk of complications.
Treasury Secretary said decades of offshoring left the United States short on critical manufacturing expertise, fueling demand for temporary foreign talent.